Insiders Buying Plus Therapeutics And 2 Other Stocks Under $2
Portfolio Pulse from Lisa Levin
Insiders at Plus Therapeutics, Inc. (PSTV), GeneDx Holdings Corp. (WGS), and Socket Mobile, Inc. (SCKT) have recently acquired shares of their respective companies. PSTV posted downbeat quarterly sales and announced a share repurchase program. WGS posted upbeat quarterly sales. SCKT posted a wider-than-expected third-quarter loss.
November 09, 2023 | 1:51 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
GeneDx Holdings Corp. Director Richard Pfenniger Jr acquired 10,000 shares at an average price of $1.49. The company posted upbeat quarterly sales.
The insider buying, combined with the upbeat sales, could be seen as a positive sign for the company's prospects, potentially leading to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Plus Therapeutics Director Robert Lenk acquired 7,395 shares at an average price of $1.61. The company posted downbeat quarterly sales and announced a share repurchase program.
The insider buying could be seen as a positive sign, indicating confidence in the company's prospects despite the downbeat sales. However, the share repurchase program could be an attempt to boost the stock price, which may not have a lasting impact.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Socket Mobile, Inc. Director Charlie Bass acquired 5,000 shares at an average price of $1.04. The company posted a wider-than-expected third-quarter loss.
Despite the insider buying, the wider-than-expected loss could negatively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100